Brokerages forecast that Motus GI Holdings Inc (NASDAQ:MOTS) will announce ($0.13) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Motus GI’s earnings, with estimates ranging from ($0.14) to ($0.12). Motus GI posted earnings per share of ($0.18) in the same quarter last year, which would suggest a positive year over year growth rate of 27.8%. The company is scheduled to issue its next earnings report on Thursday, November 12th.
According to Zacks, analysts expect that Motus GI will report full year earnings of ($0.62) per share for the current financial year, with EPS estimates ranging from ($0.65) to ($0.58). For the next fiscal year, analysts forecast that the business will post earnings of ($0.44) per share, with EPS estimates ranging from ($0.48) to ($0.38). Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that cover Motus GI.
Motus GI (NASDAQ:MOTS) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.06. Motus GI had a negative return on equity of 139.08% and a negative net margin of 16,834.35%.
NASDAQ:MOTS remained flat at $$1.02 during mid-day trading on Wednesday. 84,909 shares of the company traded hands, compared to its average volume of 122,629. Motus GI has a twelve month low of $0.46 and a twelve month high of $2.99. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.77 and a current ratio of 1.90. The firm has a market cap of $29.53 million, a PE ratio of -1.34 and a beta of 2.78. The stock has a fifty day simple moving average of $1.09 and a 200 day simple moving average of $1.08.
A hedge fund recently raised its stake in Motus GI stock. Trellus Management Company LLC boosted its stake in shares of Motus GI Holdings Inc (NASDAQ:MOTS) by 15.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 260,000 shares of the company’s stock after acquiring an additional 35,000 shares during the period. Trellus Management Company LLC owned 0.90% of Motus GI worth $175,000 at the end of the most recent reporting period. Institutional investors own 37.29% of the company’s stock.
About Motus GI
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Featured Story: Fundamental Analysis – How It Helps Investors
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.